4-year follow-up data on efficacy and safety of PCSK9 siRNA

Media formats available:

Self-assessment on statin eligibility without prescription using a web app
Self-assessment on statin eligibility without prescription using a web app
ACC.24
Self-assessment on statin eligibility without prescription using a web app
- Steven Nissen, MD
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC.24
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
- Michael Gibson, MD
Characteristics of patients with DM using icosapent ethyl in the real world
Characteristics of patients with DM using icosapent ethyl in the real world
Dyslipidemia
Characteristics of patients with DM using icosapent ethyl in the real world
- Om P. Ganda, MD
Understanding the working mechanism of EPA
Understanding the working mechanism of EPA
Dyslipidemia
Understanding the working mechanism of EPA
- Preston Mason, PhD

PACE-CME